Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. J of Skin [Internet]. 2017 Oct. 27 [cited 2026 May 2];1(3.1):s6. Available from: https://skin.dermsquared.com/skin/article/view/157